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Abstract
Purpose/Method. Transfection experiments have been used to identify activated oncogenes in a wide variety of tumour
types. Here we describe the use of transfection experiments utilizing DNA from a human pleomorphic liposarcoma to
identify a novel gene, designated lip which maps to chromosome 19.
Results. lip was expressed in all sarcoma cell lines examined and a wide variety of normal tissues. Sequencing of cDNAs
prepared from transcripts of the normal lip gene indicates that lip is predicted to encode a 966 amino acid protein with
a region of homology to proteins such as vav, dbl, lbc and ect-2 which act as GDP± GTP exchange factors for the RAS
superfamily of small GTP-binding proteins, and the N-terminal 830 amino acids are identical to the recently identi® ed
gene p115-RhoGEF, an exchange factor for RHOA. In transfectants, lip has undergone a rearrangement which results in
C-terminal truncation of the predicted LIP protein. However, we failed to detect this alteration in the primary liposarcoma
used in the original transfection experiments, or in other sarcoma specimens examined.
Discussion. When considered together, these observations suggest that transforming lip sequences represent an alterna-
tively spliced form of pll5-RhoGEF that is activated for transformation by C-terminal truncation during transfection, and
is not widely involved in sarcoma development.
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Introduction
Transfection of DNA into NIH3T3 mouse
® broblasts has been used to survey a wide variety
of human tumours for the presence of transform-
ing oncogenes. Although the majority of the
genes detected by this assay are activated ras
genes, a number of other genes including met,
1
ret, trk,
3 mas
4, dbl,
5 raf,
6 hst,
7 vav,
8 ufo/axl,
9,10
ect± 2
11 and lbc
12 have also been identi® ed.
These genes encode proteins of several func-
tional classes, including growth factors, transmem-
brane receptors with tyrosine kinase activity.
non-receptor serine± threonine kinases and
regulators of small GTP-binding proteins, all of
which are thought to play a role in intracellular
signalling pathways which regulate cellular prolifer-
ation.
In an attempt to identify oncogenes activated in
human soft tissue tumours, DNA from 29 sarcomas
was examined for the ability to transform NIH3T3
cells.
13 These studies identi® ed an activated k-ras
gene in a leiomyosarcoma, and a novel activated
gene following transfection of DNA from a
pleomorphic liposarcoma. Genomic fragments of
this novel gene, designated lip, were cloned by
screening a genomic library prepared using DNA
from a lip secondary transfectant with a human
alu-repeat probe. Repeat-free subclones of these
genomic clones have been used to demonstrate that
this gene maps to chromosome 19 and is expressed
as a 3.0-kb transcript in primary and secondary lip
transfectants.
13
cDNAs corresponding to the normal lip gene have
now been cloned from a normal ® broblast cDNA
library and through sequencing analysis were found
to encode a protein with regions of homology to
proteins such as exchange factors for small GTP-
binding proteins. In addition the N-terminal 830
amino acids are almost completely identical to the
recently cloned p115-RhoGEF.
14 Sequencing of
cDNA clones isolated from a primary transfectant
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library indicate that 39 sequences are lost during its
activation.
Materials and Methods
59 RACE polymerase chain reaction analysis
Cytoplasmic RNA was extracted from subcon¯ uent
cultures of MCF-7 cells.
15 59 RACE (rapid am-
pli® cation of cDNA ends) was performed as recom-
mended using the 59 RACE System (Gibco BRL),
with the exception that RNA was reverse tran-
scribed using random hexamer primers (Pharma-
cia). Polymerase chain reaction (PCR) primers were
as follows: ® rst round of ampli® cation GAGTTT-
GTCTCCAGCTCG, second round of am-
pli® cation CTCAAAATCCTCATCCTCAGC.
Preparation and screening of cDNA libraries
cDNA clones corresponding to the normal LIP gene
were obtained by screening a randomly primed
HT1080 cDNA library
l6 and an oligo-dT-primed
M426 human ® broblast cDNA library
l7 Clones cor-
responding to the transfected gene were obtained
from a primary transfectant cDNA library con-
structed as follows. RNA was extracted from sub-
con¯ uent cultures of transfectant cells,
l8 and
poly(A)
1 RNA selected using oligo-(dT)-cellulose
(Poly(A) Quik Kit, Stratagene). The cDNA library
was constructed in the lambda ZAP II vector
(Stratagene) using the ZAP II cDNA synthesis kit
(Stratagene). All three libraries were screened using
Biodyne hybridization membranes (Pall-Biodyne) as
previously described.
l6
cDNA sequencing
Partially deleted subclones of the cDNA inserts
were generated using exonuclease III and mung
bean nuclease (Stratagene), and these subclones
sequenced by the dideoxy chain termination
method
19 using the Sequenase Version 2.0 sequenc-
ing kit (United States Biochemicals).
Alternatively, primary transfectant poly(A)
1 RNA
was reverse transcribed using random hexamer
primers (Pharmacia) and Superscript (BRL), and
primers derived from the normal lip sequence were
used to amplify 20 ng of cDNA in 25 m l of pfu buffer
(Stratagene) containing 10 pmoles each primer, 200
m M each dNTP and 0.5 units of pfu DNA poly-
merase (Stratagene), with 30 cycles of 1 min at 92°,
1 min at 55° and 3 min at 72°. PCR products,
puri® ed by gel electrophoresis and Geneclean
(Bio101 Inc.), were digested with XhoI and XbaI
before being cloned into XhoI/XbaI cut Bluescript
(SK 1 ). Inserts sequenced as already described.
Primers pairs were as follows:
Primer 1: TACGCTCGAGACTTCTACCACAGCTTCCTG
and
Primer 2: CGTACTCGAGACATCTTCCCCAGCCTGGAC
Primer 3: GTCATCTAGAGCTATGTGACTGTACTCCAG
and
Primer 4A: CATGTCTAGAACTCCCTGAACCTCCAGCTC.
Results
Isolation and sequencing of cDNA clones
The genomic clone MC15, isolated in our previous
study,
l3 was used to screen an oligo-dT primed M426
human ® broblast library,
l7 and two clones of 3.0 kb
(11A) and 2.6 kb (13A) were isolated. Complete
bidirectional sequencing of clone 11A generated a
sequence of 3023 bp including a 39-bp polyA tail.
Although this clone corresponded in size to the 3.0 kb
transcript detected by Northern analysis in a variety of
human tumour cell lines (data not shown), the open
reading frame present in this cDNA extended to the
59 end of the sequence, raising the possibility that an
additional 59 sequence existed. The same probe was
therefore used to screen 100 000 clones from a ran-
domly primed HT1080 cDNA library and three addi-
tional clones 12C, 5A and 3B were isolated. Of these,
3B contained a 2.6-kb insert, was primed at nucle-
otide 2542 with respect to 11A and possessed an
alternative 59 end (Fig. 1(a)). Subsequent 59 RACE
analysis, using RNA derived from a human breast cell
line, was used to demonstrate that 18 bp of the 59
sequence was missing from the original clone 11A.
This upstream sequence, GAGGCTTCGGTTCCG-
GTG, did not, however, encode an upstream stop
codon or an initiating methionine. In clone 11A, there
are two methionines at the 59 terminus which con-
form closely to the Kozak consensus sequence initiat-
ing at methionine,
20 the ® rst 7 bp and the second 52
bp from the 59 end of this clone. Neither is preceded
by an in-frame stop codon. In clone 3B the methion-
ine at position 7 is absent (Fig. 2(a)). We have there-
fore chosen the methionine at position 52 as the most
likely translation start site since this is present in both
11A and 3B. If this is the case, lip encodes a single
major open-reading frame of 2898 nucleotides pre-
dicting a protein of 966 amino acids. The sequence
and the putative open-reading frame are shown in Fig.
2(b).
lip expression
lip was expressed as a 3-kb transcript in all cell lines
examined. These included the ® brosarcoma cell lines
HT1080 and Hs913T, the leiomyosarcoma lines SK-
UT-1 and SK-LMS-1, the rhabdomyosarcoma cell
lines A204, RMS and RD, the Ewings sarcoma cell
line A673, the promyelocytic leukaemia cell line HL-
60 and the carcinoma cell line A431. In addition, lip
was shown to be expressed in a variety of tissues
including tonsil, spleen, renal cortex, lung, prostate,
endometrium and breast (data not shown).lip detected by transfection of DNA 37
Fig. 1. (a) Schematic representation of the predicted lip protein, the cDNA clones 11A and 3B. The Kozak methionine codon, ATG,
present in both clones is marked, as is the in and frame stop codon. The alternative 59 sequence in clone 3B is demonstrated. The dbl
homology (DH) and pleckstrin homology (PH) domains and the potential SH3 domain-binding sites are also shown. (b) Schematic
representation of the 39 ends of clone 11A, transfectant clones T1, T5, T6, T9, T10, and T3, T2 and T7. Clones are aligned with respect
to clone 11A. The alternative 39 sequences in each of the three groups of transfectant clones are demonstrated by shading. The sequence
at the junction sites between lip, non-lip sequences in transfectant clones T2, T3, T7 is shown and indicates that the 138-bp sequence
inserted between lip nucleotides 2300 and 2301 may be a retained intron.
The predicted lip protein contains nucleotide exchange
factor and PH domains
The predicted lip protein contains regions of moder-
ate similarity to the previously described dbl homol-
ogy (DH) domain seen in the transforming
oncogenes dbl, vav, ect-2 and tim;
21 the yeast cell
cycle gene cdc24, the bcr gene
22 and a nucleotide
exchange factor for ras, p140-RasGRF.
23 Using the
FASTA search programme, the core region of this
DH domain (amino acids 416± 610) was most
closely related to the lbc, vav, ect-2 and cdc24 genes,
demonstrating 33.8%, 25.9%, 25.5% and 24.3%
identity respectively (Fig. 3(a)).
A second region of similarity to the pleckstrin
homology (PH) domain
24 has been found to span
amino acids 649 to 758. This domain, ® rst
identi® ed as an internal repeat in pleckstrin, the
major substrate of protein kinase C in platelets,
25
has been identi® ed in a number of other proteins
including the products of the vav, dbl, rasgrf, bcr, lbc
and cdc24 genes. lip shows 24% identity with the
pleckstrin C-terminal PH domain. Although the
identity is low, the family members noted so far
have exhibited only 21± 25% identity. All ® ve of the
previously de® ned subdomains can be identi® ed,
and the most highly conserved residues which de® ne
these subdomains
25 are also conserved in lip
(Fig. 3(b)).
The C-terminal 200 amino acids are relatively
proline rich (16%) and contain a number of sites
which conform to the minimal consensus sequence
for SH3 domain binding sites, P± */p± X± P
(P 5 proline, */p 5 usually hydrophobic/proline,
X 5 not conserved).
26 There is an additional poten-
tial SH3 domain-binding sequence in the amino38 H. Patterson et al.
Fig. 2. (a) The alternative 59 sequence from clone 3B and (b) the nucleotide and predicted amino acid sequence of the lip cDNA
clone 11A. 59 RACE analysis has demonstrated the presence of an additional 18-bp 59 sequence, GAGGCTTCGGTTCCGGTG, which
is missing from clone 11A. The amino acid sequence commences at the second Kozak methionine at nucleotide position 52. The ® rst
methionine at position 7 (absent from clone 3B) is underlined, the divergent sequence in clone 3B is overlined. The amino acid substitutions
within the DBL homology (DH) domain, introduced by the mismatches between clone 11A and the transfectant clones, are shown above
the nucleotide sequence, A® G at nucleotide 1481, G® A at nucleotide 1747. The DH domain is shown in bold. The PH domain
is ¯ anked by arrowheads, potential SH3 domain-binding sites are marked by asterisks above the sequence. The positions at which 11A
sequence and the sequence in clones T1, T3 diverge are marked with arrows. The stop codon TGA is marked with an asterisk below
the sequence. Nucleotide sequence is numbered on the left and amino acid sequence on the right. (c) Nucleotide and predicted amino
acid sequence of the 39 end of transfectant cDNA clone T1. The nucleotide and predicted amino acid sequences are numbered with respect
to clone 11A, and sequence common to both clones 11A and T1 is underlined. An arrowhead marks the site of the rearrangement which
replaces 188 amino acids from the predicted lip protein with 15 novel residues. The in-frame stop codon is marked with an asterisk.
(d) Nucleotide and predicted amino acid sequence of the 39 end of transfectant clone T3. Nucleotide and amino acid sequences are
numbered with respect to clone 11A, and sequences common to both clone 11A and T3 are marked with arrowheads and underlined.
The in-frame stop codon is marked with an asterisk. The rearrangement in clone T3 replaces 217 amino acids at the 39 end of clone
11A with a single novel residue.lip detected by transfection of DNA 39
Fig. 2. Continued.
phorylation at residue 487 and a single potential site
for mitogen-activated protein kinase (MAPK) phos-
phorylation, P± X± S/T± P, at residue 954 (Fig. 2(b)).
LIP shares identity with p115-RHOGEF, an exchange
factor for RHOA
p115-RHOGEF was identi® ed using RHOA as an
af® nity-puri® ed ligand, and subsequently cloned
terminal region. AASPGPSRPGL, which closely
resembles the SH3 domain binding sequences seen
in the human dynamin protein, a microtubule bind-
ing protein which has GTPase activity and is
thought to be involved in vesicle traf® cking.
27 A
Prosite database motif search reveals 13 consensus
sequences for protein kinase C phosphoryation, 13
consensus sequences for casein kinase phosphoryla-
tion, a single consensus sequence for tyrosine phos-40 H. Patterson et al.
Fig. 3. (a) Computer-generated alignment of the DH domain in LIP, ECT-2, LBC, TIM, DBL, VAV, CDC24, p140RASGRF,
BCR and murine SOS using the Clustal V programme. The consensus sequence is indicated below. A capital letter indicates six or more
of the proteins possess an identical amino acid at this position, and an asterisk that the amino acid is conserved in six or more of the
proteins. Amino acids are numbered on the left. Sequences were obtained from the GENBANK database via Northwick Park Hospital,
Middlesex, UK. (b) Alignment of pleckstrin N, pleckstrin C with LIP, VAV, DBL, CDC24, ECT-2, p140RASGRF, BCR and SOS,
over the PH domain. The proteins were aligned as previously described.
30 The conserved amino acid residues which anchor the ® ve
previously described subdomains
24 are shown in capitals below the alignment, with additional conserved residues marked with an asterisk.
from human fetal brain cDNA libraries.
14. Compari-
son of the cDNA sequences obtained for lip and
p115-RhoGEF shows alternative 59 untranslated
sequences, sequence variations resulting in six
isolated amino acid substitutions in the predicted
protein sequence and an alternative 39 end.lip detected by transfection of DNA 41
Fig. 3. Continued.
The 59 sequence identi® ed for p115-RhoEF is a
shortened version of that identi® ed in clone 3B
derived from an HT1080 cDNA library, and clone
3B extends this sequence by 26 bp. The alternative
59 sequence identi® ed in clone 11A and with 59
RACE analysis using RNA from a human breast cell
line contains an in-frame upstream methionine and
may represent an alternative start site for translation
initiation (Fig. 2b)
With the exception of the six amino acid substitu-
tions, DÝE (codon 257), PÝA (codon 259), RÝA
(codon 433), RÝH (codon 477), TÝA (codon 566)
and RÝS (codon 776), lip and p115-RhoGEF are
identical until amino acid 830. At this point the
sequence AAA/GGAGTT in lip is replaced by AAA/
GTGCTG in p115-RhoGEF. The sequence in
p115-RhoGEF is a potential intron splice donor site,
and the novel sequences seen in lip may have arisen
as a result of alternative splicing.
Analysis of the lip gene in the primary liposarcoma and
in transfectant cell lines
Hybridization of clone 11A to Southern blots of
EcoRI-digested normal genomic DNA gave bands
of 15 and 7 kb. These bands were present in tumour
DNA from the original liposarcoma, but bands of
17 and 3.7 kb were observed using DNA derived
from primary and secondary transfectant cell lines
(data not shown). This data indicated that the lip
gene might be activated by rearrangement, but if
this were the case then the rearrangement had taken
place during the transfection process and was not
present in the primary liposarcoma. To further de-42 H. Patterson et al.
lineate any role lip gene rearrangement might play in
sarcoma development, an additional 52 primary tu-
mours were evaluated by Southern analysis of
EcoRI-digested tumour DNA. This group included
12 malignant ® brous histiocytomas, 10 leiomyosar-
comas, nine liposarcomas, ® ve malignant peripheral
nerve sheath tumours, four rhabdomyosarcomas,
two synovial sarcormas, one chondrosarcoma, one
® brosarcoma, one post-irradiation spindle cell sar-
coma, one dermato® brosarcoma protuberans, one
® bromatosis, two haemangiomas, one lipoma, one
neurilemmoma and one clear cell carcinoma. In no
case was any rearrangement detected.
Analysis of the mechanism of lip activation
To examine the mechanism of activation of lip, we
prepared an oligo-dT primed cDNA library using
RNA from the lip transfectant cell line. Screening
200 000 clones using clone 11A as a probe resulted
in the identi® cation of 10 partial length cDNA
clones (T1 to T10) that were characterized by DNA
sequencing. Clone T4 exhibited 88% DNA se-
quence identity and 98% protein sequence identity
to the human lip sequence, and probably corre-
sponds to a mouse lip clone. Analysis of the remain-
ing clones revealed that they could be divided into
three groups, each of which exhibited loss of the 39
lip sequences. In clones T1, 5, 6, 9 and 10, lip was
replaced 39 to nucleotide 2387 by a new sequence
that in database searches showed regions of homol-
ogy to human alu repeat sequences. This rearrange-
ment replaces 188 amino acids at the carboxy
terminus of the predicted lip protein with 15 novel
amino acids (Figs 1(b) and 2(c)). This result was
consistent with Southern analysis data showing that
probes prepared from 39 fragments of the normal lip
cDNA failed to detect human sequences in lip pri-
mary and secondary transfectants (results not
shown). At position 1747 there was a G® A base
change converting an alanine in lip to a threonine in
the transfectant lip clone at codon 566. In addition,
T5 which was the longest of all the clones, showed
an A® G base change at position 1481 substituting
an arginine in lip for a histidine in the activated lip
clone at codon 477. The presence of these alter-
ations, which lie in the DH domain, was con® rmed
by sequencing a PCR product generated from re-
verse-transcribed lip transfectant RNA, using
primers ¯ anking this region.
The second group of cDNAs was represented by
a single clone, T3, which also encoded the G® A
alteration at codon 1747. In T3, lip sequence is
interrupted immediately after nucleotide 2300 by
138 bp of novel sequence, followed by an 87-bp
sequence corresponding to nucleotides 2301± 2387
of lip and then by 280 bp of additional novel se-
quence and a polyA tail. The novel sequences in T3
were unrelated to those in the ® rst group of clones
discussed above. In T3, lip is truncated by 216
amino acids as a stop codon is introduced immedi-
ately following the break-point (Figs 1(b) and 2(d)).
This alteration removes an invariant tryptophan
from the PH domain discussed earlier. Analysis of
the junctions between lip sequences and novel se-
quences in clone T3 suggests that the 138 bp of the
novel sequence inserted between nucleotides 2300
and 2301 may be a retained intron (Fig. 1(b)).
The third group of cDNA clones represented by
clones T2 and T7 were identical to clone T3 except
that their 39 ends were respectively 133 and 136 bp
upstream from the start of the polyA tail in T3.
Discussion
Here, we describe the cloning and characterization
of a gene detected in NIH3T3 transfection experi-
ments using DNA from a human liposarcoma. This
gene, lip, shares homology with the oncogenes dbl,
vav, ect-2, tim and lbc, and the yeast cell cycle gene
cdc24, encompassing both the DH and the PH
domains. CDC24 functions as an exchange factor
for the RHO-like protein CDC42 in budding yeast,
27
DBL is known to act as an exchange factor for
CDC42Hs and RHOA,
28 ECT-2 binds RHOC and
RAC1
11 and LBC acts as an exchange factor for
RHOA, RHOB and RHOC.
29 Moreover, with the
exception of six isolated amino acid differences, lip
is identical over its N-terminal 830 amino acids
(including DH and PH domains) to the recently
identi® ed protein p115RhoGEF, which functions as
an exchange factor for RHOA.
14 Guanine nucleotide
exchange factors bind preferentially to the nucle-
otide-depleted state of G-proteins, and by stimulat-
ing the release of GDP they promote the subsequent
binding of GTP, and hence G-protein activation.
The DH domain appears to function primarily as an
GDP± GTP exchange domain for members of the
RHO family. The PH domain
30 appears to be in-
volved in a wide variety of molecular interactions.
The C-terminal regions of several PH domains bind
to the beta-gamma subunits of heterotrimeric G-
proteins,
31,32 and the N-terminal region to phospho-
inositol-4,5-bisphosphate,
33 which implies that the
PH domain is important for membrane localization.
In all the exchange factors which possess both do-
mains, the PH domain is located immediately C-ter-
minal to the DH domain. This suggests that the PH
domain is important for the function of the exchange
factor domain.
In transfectants, lip appears to be activated by
C-terminal truncation, a rearrangement which ap-
pears to have taken place during the transfection
procedure, and was not present in the primary
liposarcoma. Moreover, examination of an addi-
tional 52 tumours by Southern analysis revealed no
evidence in support of a role for lip rearrangement in
sarcoma development.
Support for C-terminal truncation as the mechan-
ism of lip activation comes from evidence thatlip detected by transfection of DNA 43
pll5RhoGEF is activated for transformation in the
NIH3T3 focus-forming assay by both N- and C-ter-
minal truncation.
l4 Moreover, additional members
of this protein family have also been shown to be
activated by truncation.
8,11,34± 36 In general, these
activating mutations appear to involve the removal
of putative regulatory C-terminal and/or N-terminal
domains, but leave the DH and PH domains
intact.
37 In the oncogene lfc, mutation of the con-
served tryptophan residue in the PH domain abol-
ishes transforming activity as does removal of only
three amino acid residues from the N-terminal
region of its DH domain. Deletions which do not
involve the DH or PH domains do not abolish
transforming activity. In addition, replacement of
the PH domain with an alternative membrane-local-
izing signal such as an isoprenylation or myristoyla-
tion site restores transforming activity.
37 This
supports the view that the PH domain is required
for DH domain activity, which appears to be pro-
moted by localizing the exchange factor to the
plasma membrane.
lip is predicted to encode a protein with a number
of differences from p115RhoGEF. In addition to dif-
ferences in six amino acid residues within the N-ter-
minal 830 amino acids. the C-terminal 133 amino
acids are unique to lip. Within this C-terminal region
there are a number of proline-rich regions which con-
form to the minimal consensus sequence for SH3
domain binding sites.
26 SH3 domain-binding sites
have been identi® ed in a number of proteins includ-
ing, for example, the mammalian RAS exchange fac-
tor mSOS.
38 In SOS, these proline-rich sequences
mediate binding to the SH3 domains of the adaptor
protein GRB2,
39,40 an interaction which recruits SOS
to the cell membrane, where it is pivotal in the signal
transduction pathway from receptor tyrosine kinases
to RAS proteins. LIP and p115RhoGEF may rep-
resent alternatively spliced forms of the same gene,
and if the proline-rich sequences present in LIP serve
a regulatory function, perhaps via a role as SH3
domain-binding sites, then this alternative splicing
may represent a mechanism by which LIP/
p115RHOGEF function is regulated.
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